Pressure Biosciences Inc
General ticker "PBIO" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $106.9K
Pressure Biosciences Inc does not follow the US Stock Market performance with the rate: -39.2%.
Estimated limits based on current volatility of 104.5%: low -0.00$, high 0.03$
Factors to consider:
- Current price 98.3% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.15$, 0.73$]
- 2024-12-30 to 2025-12-30 estimated range: [0.17$, 0.78$]
Financial Metrics affecting the PBIO estimates:
- Negative: Non-GAAP EPS, $ of -1.54 <= 0.10
- Negative: Operating profit margin, % of -82.77 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -26.08 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Industry operating profit margin (median), % of -12.70 <= 2.14
Short-term PBIO quotes
Long-term PBIO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2.00MM | $1.73MM | $1.98MM |
| Operating Expenses | $6.19MM | $6.63MM | $11.48MM |
| Operating Income | $-4.19MM | $-4.90MM | $-9.50MM |
| Non-Operating Income | $-15.97MM | $-11.18MM | $-19.81MM |
| Interest Expense | $14.45MM | $10.44MM | $15.58MM |
| R&D Expense | $1.10MM | $0.97MM | $1.37MM |
| Income(Loss) | $-20.15MM | $-16.08MM | $-29.31MM |
| Taxes | $14.45MM | $0.75MM | $0.00MM |
| Profit(Loss) | $-34.60MM | $-16.82MM | $-29.31MM |
| Stockholders Equity | $-22.21MM | $-32.69MM | $-32.75MM |
| Inventory | $1.15MM | $0.69MM | $0.30MM |
| Assets | $2.83MM | $2.01MM | $1.05MM |
| Operating Cash Flow | $-4.87MM | $-4.48MM | $-3.19MM |
| Capital expenditure | $0.12MM | $0.02MM | $0.01MM |
| Investing Cash Flow | $-0.12MM | $-0.02MM | $-0.01MM |
| Financing Cash Flow | $5.11MM | $4.37MM | $3.27MM |
| Earnings Per Share* | $-5.21 | $-1.52 | $-1.51 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.